Tipifarnib (Zarnestra)
Jump to navigation
Jump to search
Mechanism of action
From the NCI Drug Dictionary: A nonpeptidomimetic quinolinone with potential antineoplastic activity. Tipifarnib binds to and inhibits the enzyme farnesyl protein transferase, an enzyme involved in protein processing (farnesylation) for signal transduction. By inhibiting the farnesylation of proteins, this agent prevents the activation of Ras oncogenes, inhibits cell growth, induces apoptosis, and inhibits angiogenesis.
Also known as
- Code name: R115777
- Brand name: Zarnestra